10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Amiodarone Hydrochloride 200 mg. Tablets from India
Issued February 26, 2009 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN0 N052797 (February 26, 2009)
Tariff classification
HTS codes: 3004.90.9120
Headings: 3004
Product description
The subject product, Amiodarone Hydrochloride in 200 mg. Tablet form, is an antiarryhthmic agent indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia.
CBP rationale
The applicable subheading for the Amiodarone Hydrochloride 200 mg. Tablets will be 3004.90.9120, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.
Full text
N052797 February 26, 2009 CLA-2-30:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9120 Mr. Pradeep Shah Zydus Pharmaceuticals Inc. 210 Carnegie Center, Suite 103 Princeton, NJ 08540 RE: The tariff classification of Amiodarone Hydrochloride 200 mg. Tablets from India Dear Mr. Shah: In your letter dated February 11, 2009, you requested a tariff classification ruling. The subject product, Amiodarone Hydrochloride in 200 mg. Tablet form, is an antiarryhthmic agent indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia. The applicable subheading for the Amiodarone Hydrochloride 200 mg. Tablets will be 3004.90.9120, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646)733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
The tariff classification of Bosentan Tablets in dosage form, from India
The tariff classification of Lisinopril Tablets, in dosage form, from India
The tariff classification of Enalapril Maleate Tablets, imported in dosage form, from Slovenia
The tariff classification of Xarelto® tablets in dosage form from Germany
The tariff classification of Adempas tablets in dosage form from Germany
The tariff classification of Metoprolol Succinate Extended Release Tablets and Candesartan Cilexetil Tablets, imported in dosage form, from India
The tariff classification of Ramipril Tablets, imported in dosage form, from India
The tariff classification of Sildenafil Tablets, imported in dosage form, from India
The tariff classification of Amlodipine Besylate (CAS-111470-99-6) and Benazepril Hydrochloride (CAS-86541-74-4), imported in dosage form, from India
Follow N052797
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.